Latest Lymphoma Stories
A newly-released study of the lymphoma drug brentuximab vedotin suggests it may be a treatment alternative for certain mesothelioma patients. Raleigh, NC (PRWEB)
RnRMarketResearch.com adds "Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2014" to its store.
WELSHPOOL, Wales, January 13, 2015 /PRNewswire/ -- Team We Are Promotional Products are set to visit the picture perfect settings of Lake Vyrnwy in the month of June 2015
SUNNYVALE, Calif., Jan. 12, 2015 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today provided its preliminary unaudited 2014 U.S. net product revenue results and 2015 U.S.
HUYA holds exclusive rights to chidamide as HBI-8000 ex-China SAN DIEGO, Jan.
SHENZHEN, China, Jan.
- First Patient Dosed in the "Wolverine" Phase II Trial Evaluating ProNAi's BCL2 Targeting DNAi(®) Therapeutic PNT2258 - VANCOUVER, BC and PLYMOUTH, MI, Jan.
PRINCETON, N.J., Jan. 7, 2015 /PRNewswire/ -- Soligenix, Inc.
Study to focus on mutations and deletions of CREBBP and EP300 genes in lymphomas SAN DIEGO, Jan. 6, 2015 /PRNewswire/ -- Mirati Therapeutics, Inc.
New IMBRUVICA Data from National Institutes of Health Study Published in The Lancet Oncology SUNNYVALE, Calif., Jan. 5, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
- A poem in which the author retracts something said in an earlier poem.
More Images (1 images) »